Assembly Actions -
Lowercase Senate Actions - UPPERCASE |
|
---|---|
Mar 11, 2010 |
referred to health delivered to senate passed assembly |
Jan 12, 2010 |
amended on third reading 8782a |
Jan 06, 2010 |
ordered to third reading cal.623 returned to assembly died in senate |
Jun 18, 2009 |
referred to rules |
Jun 17, 2009 |
delivered to senate passed assembly ordered to third reading rules cal.413 rules report cal.413 reported |
Jun 16, 2009 |
reported referred to rules |
Jun 15, 2009 |
reported referred to ways and means |
Jun 08, 2009 |
referred to health |
Assembly Bill A8782
2009-2010 Legislative Session
Sponsored By
DESTITO
Archive: Last Bill Status - In Senate Committee Health Committee
- Introduced
-
- In Committee Assembly
- In Committee Senate
-
- On Floor Calendar Assembly
- On Floor Calendar Senate
-
- Passed Assembly
- Passed Senate
- Delivered to Governor
- Signed By Governor
Actions
Bill Amendments
co-Sponsors
Richard Gottfried
Audrey Pheffer
2009-A8782 - Details
- Current Committee:
- Senate Health
- Law Section:
- Health
- Versions Introduced in 2011-2012 Legislative Session:
-
A4534
2009-A8782 - Sponsor Memo
BILL NUMBER:A8782 TITLE OF BILL: An act to direct the department of health to evaluate and report on Medicaid prescription drug reimbursement to retail pharma- cies PURPOSE OR GENERAL IDEA OF BILL: This bill directs the Department of Health to evaluate and report on Medicaid prescription drug reimburse- ment to retail pharmacies. SUMMARY OF SPECIFIC PROVISIONS: Section one of the bill creates a work- group within the Department of Health to assist the Commissioner of Health in studying Medicaid prescription drug reimbursement to retail pharmacies. Section two provides for what shall be analyzed by the work- ing group. Section three requires the Commissioner of Health to issue a report to the Governor and the Legislature. Section four sets forth the effective date, JUSTIFICATION: It has become important for the legislature to have access to factual information on which to base policy and budget deci- sions with regard to payments to pharmacies. This legislation requires the Health Department, working with representatives of organized pharma- cy and other stakeholders, to gather information and prepare a report to inform about the adequacy of present reimbursement in terms of actual costs both for medications and professional services.
2009-A8782 - Bill Text download pdf
S T A T E O F N E W Y O R K ________________________________________________________________________ 8782 2009-2010 Regular Sessions I N A S S E M B L Y June 8, 2009 ___________ Introduced by M. of A. DESTITO, GOTTFRIED, PHEFFER -- read once and referred to the Committee on Health AN ACT to direct the department of health to evaluate and report on Medicaid prescription drug reimbursement to retail pharmacies THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM- BLY, DO ENACT AS FOLLOWS: Section 1. The commissioner of health shall establish in the depart- ment of health a Medicaid pharmacy reimbursement workgroup (referred to in this act as the "workgroup") for the purpose of assisting the commis- sioner of health in studying Medicaid prescription drug reimbursement to retail pharmacies. The workgroup shall consist of 16 members, to be appointed as follows: 4 members shall be appointed by the governor, 3 members shall be appointed by the speaker of the assembly, 3 members shall be appointed by the temporary president of the senate, 1 member shall be appointed by the minority leader of the senate, and 1 member shall be appointed by the minority leader of the assembly. The chairs of the assembly and senate fiscal and health committees, or their designees shall serve as ex-officio members. The work group shall include: (a) 3 representatives of organizations of chain and independent retail pharma- cies, 3 prescription drug manufacturers and wholesalers, 2 advocates for Medicaid recipients, and other stakeholders; (b) 2 appropriate officials of the department of health; and (c) 2 academic or other professional experts on prescription drug reimbursement. S 2. 1. The workgroup's study shall include but need not be limited to an analysis of: (a) how the current reimbursement methodology relates to pharmacies' actual costs for wholesale purchasing of drugs and dispensing Medicaid prescriptions, including but not limited to inventory acquisition and management, payroll costs, employee benefits, professional liability insurance, licenses and other fees, professional services such as coor- dination of benefits, patient counseling and prescription verifications, EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets [ ] is old law to be omitted. LBD11995-04-9
co-Sponsors
Richard Gottfried
Audrey Pheffer
Robert Reilly
Nelson Castro
multi-Sponsors
James F. Brennan
Daniel Burling
Francine DelMonte
Earlene Hooper
2009-A8782A (ACTIVE) - Details
- Current Committee:
- Senate Health
- Law Section:
- Health
- Versions Introduced in 2011-2012 Legislative Session:
-
A4534
2009-A8782A (ACTIVE) - Sponsor Memo
BILL NUMBER:A8782A TITLE OF BILL: An act to direct the department of health to evaluate and report on Medicaid prescription drug reimbursement to retail pharma- cies PURPOSE OR GENERAL IDEA OF BILL: This bill directs the Department of Health to evaluate and report on Medicaid prescription drug reimburse- ment to retail pharmacies. SUMMARY OF SPECIFIC PROVISIONS: Section one of the bill creates a work- group within the Department of Health to assist the Commissioner of Health in studying Medicaid prescription drug reimbursement to retail pharmacies. Section two outlines the different factors to be considered in the study. Section three requires the Commissioner of Health to issue a report to the Governor and the Legislature. Section four sets forth the effective date. JUSTIFICATION: It has become important for the legislature to have access to factual information on which to base policy and budget deci- sions with regard to payments to pharmacies. This legislation requires the Health Department, working with representatives of organized pharma- cy and other stakeholders, to gather information and prepare a report to inform about the adequacy of present reimbursement in terms of actual costs both for medications and professional services.
2009-A8782A (ACTIVE) - Bill Text download pdf
S T A T E O F N E W Y O R K ________________________________________________________________________ 8782--A Cal. No. 623 2009-2010 Regular Sessions I N A S S E M B L Y June 8, 2009 ___________ Introduced by M. of A. DESTITO, GOTTFRIED, PHEFFER, REILLY, CASTRO, CHRISTENSEN, ESPAILLAT, JAFFEE, GIBSON, KOON, GUNTHER, GALEF, COOK, ROSENTHAL, PERRY, ORTIZ -- Multi-Sponsored by -- M. of A. BRENNAN, DelMONTE, HOOPER, JOHN, MAYERSOHN, MENG, SCHIMEL, WEISENBERG -- read once and referred to the Committee on Health -- reported from commit- tee, advanced to a third reading, amended and ordered reprinted, retaining its place on the order of third reading AN ACT to direct the department of health to evaluate and report on Medicaid prescription drug reimbursement to retail pharmacies THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM- BLY, DO ENACT AS FOLLOWS: Section 1. The commissioner of health shall establish in the depart- ment of health a Medicaid pharmacy reimbursement workgroup (referred to in this act as the "workgroup") for the purpose of assisting the commis- sioner of health in studying Medicaid prescription drug reimbursement to retail pharmacies. The workgroup shall consist of 16 members, to be appointed as follows: 4 members shall be appointed by the governor, 3 members shall be appointed by the speaker of the assembly, 3 members shall be appointed by the temporary president of the senate, 1 member shall be appointed by the minority leader of the senate, and 1 member shall be appointed by the minority leader of the assembly. The chairs of the assembly and senate fiscal and health committees, or their designees shall serve as ex-officio members. The work group shall include: (a) 3 representatives of organizations of chain and independent retail pharma- cies, 3 prescription drug manufacturers and wholesalers, 2 advocates for Medicaid recipients, and other stakeholders; (b) 2 appropriate officials of the department of health; and (c) 2 academic or other professional experts on prescription drug reimbursement. S 2. 1. The workgroup's study shall include but need not be limited to an analysis of: EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets [ ] is old law to be omitted. LBD11995-05-0
Comments
Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.
Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.
Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.